Table 2.
FACS antibodies used in this study.
| Antigen | Conjugate | Clone | Company | Catalog |
|---|---|---|---|---|
| CD3 | PE/Cy7 | 145-2C11 | BioLegend | 100320 |
| CD4 | Brilliant violet605 | GK1.5 | BioLegend | 100451 |
| CD4 | FITC | GK1.5 | BioLegend | 100406 |
| CD8a | PE/Cy7 | 53-6.7 | BioLegend | 100714 |
| CD11b | APC | M1/70 | BioLegend | 101212 |
| CD11c | PE/Cy7 | N418 | BioLegend | 117318 |
| CD11c | Alexa700 | N418 | BioLegend | 117319 |
| CD25 | PE/Cy7 | PC61 | BioLegend | 102016 |
| CD40 | APC | 3/23 | BioLegend | 124612 |
| CD44 | APC | IM7 | BioLegend | 103012 |
| CD80 | Pacific blue | 16-10A1 | BioLegend | 104724 |
| CD80 | Brilliant violet421 | 16-10A1 | BioLegend | 104726 |
| CD86 | PE | GL-1 | BioLegend | 105008 |
| I-A/I-E | FITC | M5/114.15.2 | BioLegend | 107605 |
| TCRβ | PE | H57-597 | BioLegend | 109208 |
| TCRVα2 | PE | B20.1 | BioLegend | 127808 |
| CXCR5 | PE | L138D7 | BioLegend | 145504 |
| PD-1 | APC | J43 | eBioscience | 17998582 |
| PD-L1 | PE | 10F.9G2 | BioLegend | 124308 |
| IL-12p40/70 | APC | C15.6 | BD Pharmingen | 554480 |
| IFN-γ | PE/Cy7 | XMG1.2 | BioLegend | 505826 |
| IL-23 p19 | eFluor 660 | fc23cpg | eBioscience | 50-7023-82 |
| Rabbit IgG | Alexa647 | Invitrogen | A32733 |